Research ArticleCancer

Off-Target Lapatinib Activity Sensitizes Colon Cancer Cells Through TRAIL Death Receptor Up-Regulation

See allHide authors and affiliations

Science Translational Medicine  08 Jun 2011:
Vol. 3, Issue 86, pp. 86ra50
DOI: 10.1126/scitranslmed.3001384

Log in to view PDF

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine